Filing Details

Accession Number:
0001140361-12-011413
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-28 14:00:24
Reporting Period:
2012-02-24
Filing Date:
2012-02-28
Accepted Time:
2012-02-28 14:00:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1274826 Robert Baffi C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Evp, Technical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-24 16,313 $6.13 99,806 No 4 M Direct
Common Stock Acquisiton 2012-02-24 75,000 $11.74 174,806 No 4 M Direct
Common Stock Disposition 2012-02-24 91,313 $34.84 83,493 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2012-02-24 16,313 $6.13 16,313 $6.13
Common Stock Stock Option (right to buy) Common Stock Disposition 2012-02-24 75,000 $11.74 75,000 $11.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
694,888 2006-06-07 2015-01-06 No 4 M Direct
619,888 2006-07-13 2016-01-13 No 4 M Direct
Footnotes
  1. The price in Column 4 is a weighted average price. The prices actually received ranged from $34.55 to $35.19. the reporting person will provide to the issuer, any security holder of the issuer, or SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  2. Original option grant vested 6/48ths on July 7, 2005 and 1/48th on the 7th of every month thereafter.
  3. Original option grant vested 6/48ths on July 13, 2006 and 1/48th on the 13th of every month thereafter.